Prot #AAA-III-01: A multicentre, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with (superscript 177)Lu-DOTA(superscript 0)-Tyr(superscript 3)-Octreotate to Octreotide LAR in patients with inoperab